Delivery Order SPE2DB20D3101-SPE2DB24FRSH7

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,914.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566903471 - DEXTROAMP-AMPHETAMIN 20 MG TAB 100S, with a completion date of January 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,146.91, is for the delivery of 4567059433 - DEXTROAMP-AMPHETAMIN 30 MG TAB 100S. It is a firm fixed-price delivery order contract with a completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,485.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566845399 DEXTROAMP-AMPHETAMIN 30 MG TAB 100S, with a performance period running through January 7, 2025. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the federal government - one with the DLA Troop Support Medical valued at $999,999,999...
This federal contract award, valued at $1,509.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXTROAMP-AMPHET ER 20 MG CAP 100S, a pharmaceutical product, with a performance period through April 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,973.70 firm fixed-price delivery order is for the supply of 4565611366 DEXTROAMP-AMPHETAMIN 10 MG TAB 100S. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $1,473.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,027 units of the pharmaceutical product DEXTROAMP-AMPHETAMIN 20 MG TAB 100S. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 24, 2025. It is not associated with any set-aside program....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,128.68, is a delivery order for the supply of DEXTROAMP-AMPHETAMIN 10 MG TAB 100S, a prescription medication. The contract has an ultimate completion date of January 7, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,811.42 firm fixed-price delivery order is for the supply of 4560731772 DEXTROAMP-AMPHETAMIN 20 MG TAB 100S, a type of pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,087.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564513126 - DEXTROAMP-AMPHETAMIN 15 MG TAB 100S, a prescription pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,169.94 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The contract is for the supply of DEXTROAMP-AMPHET ER 25 MG CAP 100S, a pharmaceutical product, to support military healthcare programs globally....
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRSH7
    Delivery Order

This federal contract award, valued at $1,576.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565511309 - DEXTROAMP-AMPHETAMIN 30 MG TAB 100S, a pharmaceutical product.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about any major subcontractors. The DLA is the funding agency for this contract, which aligns with their role in supporting the medical needs of the U.S. military and other federal beneficiaries.

Generated 2/27/25, 12:10 PM